- Home
- SOPH vs JGH Comparison
SOPH vs JGH Comparison
Compare SOPH & JGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SOPH | JGH |
|---|---|---|
| Founded | 2011 | 2014 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 374.1M | 353.5M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SOPH | JGH |
|---|---|---|
| Price | $4.90 | $12.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 84.0K | 75.5K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.85% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $23.09 | N/A |
| Revenue Next Year | $19.57 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.59 | $11.80 |
| 52 Week High | $5.70 | $13.70 |
Technical Indicators
Market Signals| Indicator | SOPH | JGH |
|---|---|---|
| Relative Strength Index (RSI) | 49.55 | 49.64 |
| Support Level | $4.56 | $12.48 |
| Resistance Level | $5.46 | $12.92 |
| Average True Range (ATR) | 0.38 | 0.18 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 36.48 | 54.24 |
Price Performance
Historical ComparisonAbout SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About JGH Nuveen Global High Income Fund of Beneficial Interest
Nuveen Global High Income Fund operates as a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The Fund's securities include U.S. high-yield bonds; non-U.S. high-yield bonds from developed and emerging markets; and other income-producing investments such as preferred and convertible securities.